Atossa Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.34

+0.01 (+0.19%)

As of Feb 8, 2:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +57.7% upside

Low Target $5.85

Average Target $8.42

High Target $9.99

Current Price $5.34

Current
$5.34

Target
$8.42

$5.85 $8.42 avg $9.99

Scenario Analysis

Bear Case

$5.85

9.6%

Low target

Base Case

$8.42

+57.7%

Avg target

Bull Case

$9.99

+87.1%

High target

Risk/Reward

9.1x

Highly favorable

Price in Context

52-Week High

$8.41

-36.5% from high

52-Week Low

$5.48

+-2.6% from low

Target vs 52W High

$8.42

+0.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%